Rules and Regulations. Announcement of meeting; request for comments; correction
242 words·~1 min read·
/register/2012/09/17/2012-22793·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Chapter I [Docket No. FDA-2012-N-0780] Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Notice of Meeting; Request for Comments; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Announcement of meeting; request for comments; correction. SUMMARY: The Food and Drug Administration
(FDA)is correcting a document that appeared in the **Federal Register** of August 14, 2012 (77 FR 48491). The document announced a meeting entitled “Regulatory New Drug Review: Solutions for Study Data Exchange Standards.” The document was published with an incorrect email address. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Ron Fitzmartin, Office of Planning & Informatics, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 1160, Silver Spring, MD 20993-0002, 301-796-5333, FAX: 301-847-8443, email: *CDERDataStandards@fda.hhs.gov* . SUPPLEMENTARY INFORMATION: In FR Doc. 2012-19748, appearing on page 48491 in the **Federal Register** of August 14, 2012, the following corrections are made: 1. On page 48491, in the first column, in the FOR FURTHER INFORMATION CONTACT section, the email address “ *CDERDataStandards@hhs.fda.gov* ” is corrected to read “ *CDERDataStandards@fda.hhs.gov* .” 2. On page 48491, in the second column, in the SUPPLEMENTARY INFORMATION section, under “ *Registration,* ” the email address “ *CDERDataStandards@hhs.fda.gov* ” is corrected to read “ *CDERDataStandards@fda.hhs.gov* .” Dated: September 11, 2012. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2012-22793 Filed 9-14-12; 8:45 am]